Notice of Registration - 2012
[Federal Register Volume 77, Number 54 (Tuesday, March 20, 2012)]
[Notices]
[Pages 16264-16265]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-6696]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances, Notice of Registration;
Halo Pharmaceutical Inc.
By Notice dated December 2, 2011, and published in the Federal
Register on December 14, 2011, 76 FR 77850, Halo Pharmaceutical Inc.,
30 North Jefferson Road, Whippany, New Jersey 07981, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the following basic classes of
controlled substances:
| Drug |
Schedule |
| Dihydromorphine (9145) |
I |
| Hydromorphone (9150) |
II |
Dihydromorphine is an intermediate in the manufacture of
Hydromorphone and is not for commercial distribution.
[[Page 16265]]
The company plans to manufacture Hydromorphone HCL for sale to other
manufacturers and for the manufacture of other controlled substance
dosage units for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Halo Pharmaceutical Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Halo Pharmaceutical Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance
with 21 CFR 1301.33, the above named company is granted registration as
a bulk manufacturer of the basic classes of controlled substances
listed.
Dated: March 8, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-6696 Filed 3-19-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
